Curis reported $5.09M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Amgen AMGN:US $ 1.33B 99M
AstraZeneca AZN:LN 3.27B 209M
Bayer BAYN:GR 4.47B 527M
Bristol Myers Squibb BMY:US $ 1.78B 46M
Chimerix CMRX:US 5.84M 208K
Curis CRIS:US $ 5.09M 584K
Eli Lilly And LLY:US $ 1.63B 67.2M
Epizyme EPZM:US $ 24.11M 3.09M
Exelixis EXEL:US $ 122.76M 19.9M
Gilead Sciences GILD:US $ 1.36B 274M
GlaxoSmithKline GSK:LN 1.96B 726M
Merk MRK:US $ 2.42B 118M
Mirati Therapeutics MRTX:US $ 54.23M 277K
Novartis NOVN:VX 3.59B 91M
Pfizer PFE:US $ 3.2B 506M
Spectrum Pharmaceuticals SPPI:US $ 9.38M 485K
Takeda 4502:JP 231.48B 8.05B
Tg Therapeutics TGTX:US $ 12.64M 7.97M
Verastem VSTM:US $ 6.51M 580K
Xoma XOMA:US $ 5.71M 594K
YTE INCY:US $ 253.28M 43.69M
Ziopharm Oncology ZIOP:US $ 3.43M 76K